
|Articles|July 1, 2001
The American Journal of Managed Care
- July 2001
- Volume 7
- Issue 7
Economic Evaluation of Lamivudine Compared with Interferon-Alpha in the Treatment of Chronic Hepatitis B in the United States
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Revumenib Granted FDA Approval for R/R NPM1-Mutated AML
4
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
5















































